Since Nuttall's (1) initial observation that cell-free serum is destructive of bacteria, other investigations (2) have disclosed that bacterial lysis by serum usually occurs as a result of the interaction of a specific antibody and complement. However, bactericidal effects for many different microorganisms can frequently be found in the same serum (3). Often this bactericidal activity cannot be satisfactorily explained on an ecological basis. The characteristics of naturally occurring bacteriolytic substances have therefore been obscure and differing opinions have resulted concerning their immunologic specificity. The investigations by Mackie and Finklestein indicated that naturally occurring bactericidins are immunologically specific since absorption by homologous organisms removed specific antibodies. Gordon and Carter (4), however, were unable to demonstrate any specificity for the naturally occurring bactericidal substances.
specific antibodies, a bacterium was used which is rarely capable of producing human infections. The bactericidal effect of normal and acute phase sera for Bacillus subtilis was therefore studied. The results reveal that serum develops a significant increase of destructive action for this organism during the acute stage of a variety of diseases. If repeated determinations of bactericidal activity are made in an individual patient, a progressive decrease of destructive action occurs during convalescence and recovery. A point of particular significance is that the serum bactericidal factor for B. subtilis requires calcium. A strongly bactericidal serum can be made completely unreactive for B. subtilis if calcium is removed. If an optimum calcium concentration is restored to such a serum, it again becomes bactericidal.
EXPERIMENTAL
(a) Human blood to be studied for bactericidal activity against B. subtiUs was collected under aseptic conditions in glass test tubes and allowed to coagulate. Serum was then collected after centrifugation and stored in glass test tubes at ice box temperatures (4°C.). No significant decrease of bactericidal activity was detected after 6 to 8 months' storage under these conditions.
(b) The bactericidal studies were carried out with a strain of Bacillus subtilis obtained from the Department of Bacteriology's type collection. This particular strain was found to resist the bactericidal action of penicillin up to a concentration of 5 units per millilitre. Thus, assay of sera of patients undergoing antibiotic therapy with penicillin could be carried out. A quantitative determination of serum bactericidal activity for B. subtilis was made by determining the residual bacterial count after incubation of serum with a suspension of organisms. This was done by plate counts of serial tenfold dilutions of inoculum and similar dilutions of serum to which organisms had been previously added.
The inoculum of B. subtilis was prepared by inoculating 0.2 ml. of a 24 hour growth of B. subtilis into a test tube containing 10 ml. of Douglas broth. The inoculated broth was incubated at 37°C. until a diffuse homogeneous growth had resulted (usually 3 to 4 hours). The suspension was then centrifuged for 10 minutes at 2500 a.P.~t, in order to sediment the bacteria. The broth was removed by decantation and the bacteria were resuspended in 10 ml. of 0.85 per cent sodium chloride solution (pH 7.3) and mixed until a uniform suspension was obtained. This suspension usually contained 2 to 3 million organisms in each 0.1 ml. and was utilized for inoculation of sera to be tested.
Aliquots of 0.1 ml. of the saline suspension of B. subtilis were added to 0.5 ml. amounts of sera contained in cotton-stoppered, sterile glass tubes measuring 0.5 X 3.0 cm. Sufficient 0.85 per cent sodium chloride solution was then added to bring the volume of serum and inoculated organisms to 1.0 ml. The mixture was vigorously shaken and incubated at 37 °. At a varying period thereafter (usually 2 hours) an aliquot of 0.1 ml. was removed and serial tenfold dilutions were made in Douglas broth. A 0.1 ml. aliquot of each of these dilutions was pipetted into a Petri dish. To this was added approximately 15 ml. of melted Douglas agar and by vigorous rotation the organisms were thoroughly distributed within the agar. After incubation for 18 hours at 37°C., a colony count was made of the agar plates in which 10 to 200 colonies had grown. The number of colonies multiplied by the dilution factor represented the number of bacteria contained in a particular inoculum or serum-inoculum mixture. All dilutions were carried out by using a separate sterile pipette for each dilution.
In many instances, triplicate assays were made both of the sera to which B. sub~ilis had been added and of the inoculating suspension. When the enumeration of bacteria by this technique resulted in a range of 50,000 to 90,000 bacteria a variation of 4-10,000 bacteria was present. When the range was 500,000 to 1,000,000 organisms, a variation of -4-100,000 was found. In the range of 1,000,000 to 4,000,000 a considerable error was present. As will be observed in subsequent experiments, no significance was given to any result which did not fall considerably beyond these variations. * Five-tenths mlllilltre aliquots of sera 1 to 10 were inoculated with 0.1 ml. suspension of B. s~t/l/s containing 1,000,000 organisms; sera 11 to 16 were similarly inoculated with 440,000 organisms. After 2 hours' incubation at 37°C., an enumeration of the residual bacteria was made by plate count. Table   I are representative of assays made on approximately 300 abnormal and 100 normal human sera. The results of a study of normal serum obtained from medical students and a group of adolescent boys reveal that an insignificant degree of bactericidal activity for B. subtilis is present. No inhibition of growth is apparent when a large inoculum is used, whereas a slight inhibitory effect is found after inoculation of fewer bacteria. In instances in which a moderate increase of bactericidal activity is found in a presumed normal individual, a respiratory infection is usually present to explain the observed elevation.
Bactericidal Action of Human Sera for B. subtilis:---The data shown in
In distinction to the results found in normal sera, abnormal sera obtained from a group of patients with a variety of medical and surgical diseases show striking increases of bactericidal activity for B. subtilis. This enhanced bactericidal effect is present in the sera of patients with such unrelated diseases as carcinomatosis, coronary occlusion, orchitis resulting from the virus of epidemic parotitis, bacterial pneumonia, acute rheumatic fever,: or tuberculosis ( Table I) .
A study of thirty patients with bacterial lobar pneumonia of different pneumococcal types reveals that during the acute phase of the illness a complete destruction of as many as 3 to 4 million B. subtilis organisms for each 0.5 ml. of serum occurs. During convalescence and recovery, a progressive decrease in the inhibitory effect results. Whenever a patient with lobar pneumonia received large amounts of penicillin, the serum inhibitory effect for B. subtil~s could be blocked by the addition of potassium oxalate, demonstrating that penicillin was not causing destruction of this microorganism.
The bactericidal activity of sera from fifteen patients with acute rheumatic fever was studied. Most of these patients had 6 to 8 determinations made throughout the course of their illness. During the acute phase of this illness, complete destruction of I to 2 million organisms for each 0.S ml. of serum is observed. Subsequently, a decreasing bactericidal effect is found as the patient recovers. This decrease does not necessarily parallel a decrease of temperature but usually correlates well with a decreasing erythrocyte sedimentation rate.
The degree of enhanced bactericidal effect cannot be correlated with the increase of circulating leucocytes or lymphocytes. In a group of 20 patients with various types of malignant disease, many were found to have normal temperatures and normal leucocyte counts. The sera of these patients, however, consistently reveal a significantly enhanced bactericidal activity for B. subtilis.
The sera of five patients with acute myocardial infarction were assayed for bactericidal activity. A moderate increase is usuaUy found within 24 hours of the onset of a coronary occlusion, whereas a marked increase occurs after 3 to 4 days, the period of maximum muscle necrosis. As the patients recover a decreasing bactericidal activity is found. Observations made on sera of patients with rheumatoid arthritis, tuberculosis, bacterial peritonitis, miscellaneous virus infections, or allergic reactions such as serum sickness reveal similar enhancement of bactericidal effect for B. subtilis. In these instances also, the degree of increased bactericidal effect appears to be a reflection of the degree of stress to which the individual is subjected.
The killing action of serum possessing increased bactericidal activity takes place soon after B. subtilis is added to it. Within S minutes following addition d as many as 6,000,000 organisms to 0.S ml. of potent serum the number of bacteria are reduced to several thousand. Within IS minutes the number of organisms is reduced to a few hundred, and an hour later no organisms can be detected. Serial stained smears of the serum-bacterial mixture confirm the rapid disappearance of bacteria. Sera which have insuflficient bactericidal effect to cause complete destruction of bacteria show a similar rapid initial decrease of organisms. A maximum decrease is present after 90 to 120 minutes of incubation at 37°C., following which time, bacterial proliferation begins and within 24 hours, a dense flocculent growth results.
Influence of Physical Changes on Serum Bactericidal Substances-
The effect of pH on bacterial growth and the inhibitory factor of serum was determined by the addition of 0.1 N HCI or 0.1 s NaOH to serum in sufficient quantity to produce a pH range of 6.4--9.4 (determined by glass electrode). Each sample of serum was kept at a constant
Effect Of Variation in ]
6.4 7.4 8.5 9.5 31.0 X 10 ~ 0.6X 10 z 1.7 X 10 ~ 3.2 X 10 s * A normal and an acute phase serum were adjusted to varying degrees of pH. One-tenth millilitre of a suspension of B. subtilis containing 1,000,000 organisms was inoculated. The residual bacteria, after incubation for 2 hours at 37°C., were determined by means of plate counts of serial tenfold dilutions of serum and bacteria mixture.
volume by the addition of necessary amounts of 0.85 per cent sodium chloride solution of desired pH. B. subtilis was then inoculated into the respective sera, which were incubated for 2 hours at 37°C. The results of this experiment are shown in Table II. Normal serum exhibits little change in bactericidal activity in the range of pH 7.4-8.4. At pH 6.5 a slight increase in bacterial growth is observed. At pH 9.4 bacterial growth is considerably inhibited. The serum possessing increased bactericidal activity shows little change in inhibitory level in the pH range of 7.4-8.4. Some decrease of inhibition occurs at pH 6.4 and 9.4. Since serum after storage at 4°C. is found to have pH values of 7.6-8.4, it is unlikely that this variation has any influence on its bactericidal activity for B. subtilis.
Prolonged storage of serum at 4°C. causes no significant decrease of bactericidal activity. When such stored sera are analyzed for complement, no hemolytic activity can be detected in a sensitized sheep-cell system. If strongly bactericidal sera are heated at 56°C. for 60 minutes, a considerable loss of bactericidal effect is observed.
InitiaLly, a method for assay of serum inhibitor by dilution of serum in broth was considered desirable. It was observed, however, that as little as 0. >2,000,000
:> 2,000,000
1,200,000
Increasing concentrations of sodium oxalate were added to sera with varying degrees of bactericidal activity. A suspension of B. subtilis was added to each tube and the scram-bacteria mixture incubated for 2 hours at 37°C. The residual bacterial count was then made by plate count.
* 0.1 M concentration --(1.34 rag./0.1 ml.)
1,350,000 organisms/0.i ml.
substance is not due to phosphate ion alone becomes apparent when sodium citrate or oxalate is added to serum. Table III is illustrative of the effect of sodium oxalatc on serum bactericidal activity. Increasing amounts of oxalate were added to 0.5 ml. aliquots of sera. In serum 1, 1.34 rag. of sodium oxalate causes a decrease in inhibitor effect for B. subtilis. Serum 3, which has the highest bactericidal activity, requires 5.36 rag. of sodium oxalate before a significant inhibition of bactericidal activity resuits. If serum is treated in a similar manner with sodium citrate the bactericidal activity decreases as the concentration of sodium citrate is increased. The sodium salts of oxalic, citric, and phosphoric acids do not appear to have any growth-promoting effect on B. subtilis since addition of these salts to Douglas broth produces no difference from the growth obtained in a control broth after 2 hours' incubation at 37°C.
A complete restoration of the serum bactericidal effect is brought about if the oxalate or citrate is neutralized by equimolar concentrations of calcium chloride. This fact is shown in Table IV. Three-tenths millilitre amounts of 0.1 M sodium oxalate were added to 0.5 ml. aliquots of strongly bactericidal sera. Fifteen minutes later, 0.3 ml. of 0.1 ~ CaCI.. was added, followed by 0.1 ml. of a suspension of B. subtilis. Upon incubation for 2 hours plate counts were made.
It will be observed that complete inhibition of growth occurs in the untreated sera whereas the oxalate-treated serum exhibits no inhibitory power for B. subtilis. The serum treated with both sodium oxalate and calcium chloride has 120 No growth * Serum from a patient with fever due to malaria inocula was treated with sodium oxalate or citrate as indicated in the table. Fifteen minutes later, calcium chloride, magnesium chloride, or sodium chloride solutions were added. A 0.1 ml. suspension of B. subtilis containing 1,000,000 organisms was added and after incubation for 2 hours at 37°C., the residual bacterial count was determined.
the same degree of bactericidal activity for B. subtilis as the untreated serum. When the oxalated serum is treated with an equimolar concentration of magne, slum chloride, no restoration of bactericidal activity is apparent. Results identical to these are obtained when sodium citrate is substituted for sodium oxalate.
Strongly reactive sera were subjected to dialysis against distilled water in order to determine whether the bactericidal activity could be removed by this technique. A measured quantity of serum was placed in a sterile cellophane bag and dialyzed at 4°C. against frequent changes of distilled water for 5 days. Mter adjustment of pH to 7.3 and dilution with an equal amount of 0.85 per cent sodium chloride solution, a suspension of B. subtilis was added. The determination of bactericidal activity by a plate count of the residual organisms after 2 hours' incubation at 37°C. revealed that no loss of inhibition had occurred.
By means of cationic exchange resins, it has been shown that sufficient calcium can be removed from plasma to prevent coagulation (8) . Acute phase sera were therefore treated with a cationic resin by the technique described by Quick (8) . After adsorption in this manner, the sera were adjusted to pH 7.3 with 0.1 N NaOH and the bactericidal activity was determined. No decrease in inhibitory effect for B. subtilis was found.
These data show that calcium is a critical factor for the mediation of serum bactericidal activity against B. subtilis. The failure of dialysis and cationic adsorption to decrease the inhibitory effect of serum suggests that sufficient bound calcium remains to maintain the bactericidal activity of these sera.
Comparison of Bactericidal Effect of Serum for B. subtilis with the C-Reactive Protein:--Interesting similarities exist between the characteristics of the serum bactericidin for B. subtilis and the C-reactive protein described by Tillett, Francis, Abernethy, Avery, MacLeod (9), and Ashe (10) . These observers found that acute phase serum contains a protein which is reactive with the C carbohydrate of the pneumococcus. Moreover, this C-reactive protein does not produce a precipitin reaction unless calcium is present. More recently, L~ifstrom (11) has shown that an identical protein is reactive with a type 27 pneumococcus to cause non-specific capsular swelling. This reaction also requires calcium.
Experiments were carried out to determine whether the C-reactive protein might be the same substance which causes destruction of B. subtilis. Human sera were selected which had increased amounts of C-reactive protein and bactericidal substance for B. subtilis. These sera were absorbed by the use of either C-carbohydrate 1 or type XXVII pneumococci. 1 Mter absorption, each serum was titrated against C-carbohydrate and type XXVII pneumococci. None of the absorbed sera formed a precipitin reaction with C-carbohydrate or a quellung reaction with type XXVII pneumococci, indicating that complete removal of C-reactive protein had resulted. A suspension of B. subtilis was then added to both absorbed and untreated sera and, after incubation for 2 hours, plate counts were made to determine the degree of bacterial inhibition. The results of this procedure (Table V) reveal that considerable bactericidal activity remains in absorbed sera.
The heat stability of the C-reactive protein described by LSfstrom has been confirmed by our observation that the titre of acute phase sera for type XXVII pneumococci is not reduced by heating of serum at 5CC. for 60 minutes. If these same heated sera are assayed for bactericidal activity for B. subtilis, a marked reduction of destructive effect is found. This evidence suggests that the bactericidal activity of serum is not caused by the C-reactive protein.
Simultaneous determinations of the C-reactive protein titre for type XXVII pneumoeoccus and bactericidal activity against B. subtills were made in ap-proximately 200 acute phase sera. Usually a parallel increase and decthne of each substance are present in consecutive sera of patients with a self-limited illness such as pneumonia. At times, however, wide discrepancies are found. Occasionally a serum is encountered which has a significantly increased titre for type X X V I I pneumococcus but little inhibitory effect for B. subtilis. These observations are additional evidence that the C-reactive protein and the bactericidal substance in serum are different although each requires calcium before their characteristic effects are manifested. * Serum was absorbed with either C carbohydrate or type X X V I I pneumococci until it no longer formed a precipitin or a quelling reaction. A 0.1 ml. suspension of B. subtilis containing 270,000 organisms was added to each serum sample and after incubation for 2 hours at 37°C., the bacterial count was determined. Three-tenths millilitre amounts of 0.1 M sodium oxalate were added to untreated sera in order to compare the growth characteristics of the inoculum under conditions of inhibited bactericidal activity.
:~ Absorbed with equal volume of 1:10,000 C carbohydrate. § Absorbed with packed type XXVII pneumococci.
DISCUSSION
A remarkable capacity of sera from patients with acute infections, carcinoma, or other diseases to destroy B. subtilis is revealed by this investigation. The level of bactericidal activity appears to be closely related to the degree of stress caused by any pathological process. A maximum activity is present, for example, during the acute stage of pneumonia, whereas a decreasing destructive effect is present as the patient improves. Similarly, in acute rheumatic fever an increased bactericidal activity persists as long as the disease is active, but in convalescence a slow decrease occurs. When evidences of a disordered metabolism, such as leucocytosis and fever, are absent as in some patients with carcinoma, a considerable increase of bactericidal activity for B. sublilis is often found. This latter change does not, therefore, appear to be related to leucocytosis, nor to any metabolic change associated with fever.
Certain characteristics of the serum bactericidal substance are of significance in differentiating it from a specific antibody protein. The one of greatest ira-portance is that the B. subt~s bactericidal factor requires calcium before destruction of organisms can take place. The evidence for this is found in experiments in which decalcification of serum by means of sodium salts of phosporic, citric, or oxalic acids causes a loss of serum inhibitory activity. When equimolar concentrations of ionized calcium are added to sera treated in this manner, a restoration of inhibitory activity occurs. That the effect of calcium is specific is shown by the fact that similar concentrations of ionized magnesium fail to completely restore bactericidal activity. Since dialysis of serum or treatment with cationic exchange resins fails to diminish bactericidal activity, it seems likely that the serum bactericidal effect can be maintained by the residual bound calcium.
The stability of serum bactericidin for B. suhtilis after prolonged storage at 4°C. differentiates it from the heat-labile fraction of complement. Moreover, the fact that calcium and not magnesium restores bactericidal activity is further evidence that the bactericidin differs from complement (12) .
A striking similarity exists between the C-reactive protein described by Tillett and Francis (9) and serum bactericidal activity for B. subt~is. Each is increased as a result of acute infection, and each requires calcium. By means of absorption experiments and by the differential effect of heating of sera it appears, however, that these two serum factors are actually different. Furthermore, certain sera were found to contain considerably increased amounts of C-reactive protein yet had little bactericidal activity for B. subtilis. These observations point out dissimilarities of the two substances despite the fact that both have an intimate relationship to calcium.
The reported instances of increased bactericidal activity of acute phase sere for various microorganisms suggest that the serum bactericidal agent for B.
anthracis (5) , Streptococcus kemolyticus (6) , and other microorganisms (7) may depend on a single bactericidin-calcium substance which is unrelated to complement or a specific antibody function. If this hypothesis is substantiated by subsequent investigations, a means of body defense against bacterial invasion, uniquely different from the complement-antibody destructive action and the phagocytic reaction, may be revealed. SUMMARY An enhanced bactericidal activity of human serum for B. subtilis develops during many different forms of illness, e.g. carcinoma, virus and bacterial infections, and during acute coronary occlusion.
This increased bactericidal effect cannot be related to leucocytosis, fever, serum complement, C-reactive protein, or a specific antibody reaction.
The serum bactericidal factor becomes inactive in decalcified serum, but active again when optimal concentrations of calcium are added. Magnesium does not cause reactivation.
